Cargando…
Lipoprotein Glomerulopathy, First Case Report from Canada
Lipoprotein glomerulopathy (LPG) is caused by a mutation in the apolipoprotein E gene (APOE) gene and is characterized by lipoprotein thrombi in glomerular capillaries. Here, we describe a case of LPG, the first to be reported from Canada and the first case of LPG in North America to be associated w...
Autores principales: | Ting, Julie Anne, McRae, Susanna A, Schwartz, Daniel, Barbour, Sean J, Riazy, Maziar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233511/ https://www.ncbi.nlm.nih.gov/pubmed/35761986 http://dx.doi.org/10.2147/IJNRD.S364890 |
Ejemplares similares
-
Podocyte Infolding Glomerulopathy, First Case Report From North America
por: Ting, Julie Anne, et al.
Publicado: (2021) -
The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review
por: Liu, Huixia, et al.
Publicado: (2022) -
Double-Positive Anti–Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients
por: Ting, Julie Anne, et al.
Publicado: (2023) -
Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
por: Magistroni, Riccardo, et al.
Publicado: (2013) -
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
por: Russi, Gianpaolo, et al.
Publicado: (2009)